Concepedia

Harry Samaroo

HS

4

Publications

504

Citations

4

H-Index

2011

Active since

Affiliations

Pfizer (United States)(Current)

Harry Samaroo is an author at Pfizer (United States) specializing in medicine, natural sciences, and neurodegenerative diseases.

Top concepts

Publications per year

2011–2015

4

Publications

4

Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expression

Anastasia G. Henry, Soheil Aghamohammadzadeh, Harry Samaroo et al. · Human Molecular Genetics · 2015 · 243 citations · Full text

, , +21

Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis

Diane Stephenson, Sharon O'Neill, Sapna Narayan et al. · Molecular Autism · 2011 · 174 citations · Full text

Phosphoproteomic evaluation of pharmacological inhibition of leucine‐<scp>rich</scp> repeat kinase 2 reveals significant off‐target effects of <scp>LRRK</scp>‐2‐<scp>IN</scp>‐1

Gregory C. Luerman, Chuong Nguyen, Harry Samaroo et al. · Journal of Neurochemistry · 2013 · 65 citations · Full text

, , +18

High throughput object-based image analysis of β-amyloid plaques in human and transgenic mouse brain

Harry Samaroo, Alan Opsahl, Jan Schreiber et al. · Journal of Neuroscience Methods · 2011 · 22 citations

, , +14

Rows per page

1–4 of 4